Diltiazem HCl 125 mg in 0 recalled over sterility concerns
- Recall date
- November 9, 2023
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- SCA Pharmaceuticals, LLC recalls Diltiazem HCl 125 mg in 0.9% Sodium Chloride Injection (Concentration = 1mg/mL), 125 mL Bag, Rx only, SCA Pharmaceutica…
- Recall number
- D-0394-2024
- FDA classification
- Class II
- Brand / firm
- SCA Pharmaceuticals, LLC
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Diltiazem HCl 125 mg in 0.9% Sodium Chloride Injection (Concentration = 1mg/mL), 125 mL Bag, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095; NDC 70004-0541-35, Bar Code 70004054135
Get recall alerts
Free email alert whenever SCA Pharmaceuticals, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: SCA Pharmaceuticals, LLC